COLGATE PALMOLIVE CO annual report, Q4 FY2002

Business Context and Reporting Period

Company: Colgate-Palmolive Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Business Overview: A leading global consumer products company founded in 1806, operating in over 200 countries. The Company manages two primary segments: Oral, Personal, Household Surface and Fabric Care; and Pet Nutrition (Hill's). Key brands include Colgate, Palmolive, Softsoap, Mennen, Ajax, Fab, Science Diet, and Prescription Diet.

Key Financial Metrics (2002)

Metric 2002 2001 2000
Net Sales $9,294.3 million $9,084.3 million $9,004.4 million
Gross Profit $5,070.1 million $4,849.4 million $4,747.4 million
Gross Margin 54.6% 53.4% 52.7%
Operating Profit $2,013.1 million $1,834.8 million $1,740.5 million
Net Income $1,288.3 million $1,146.6 million $1,063.8 million
Diluted EPS $2.19 $1.89 $1.70
Operating Cash Flow $1,611.2 million $1,503.9 million $1,536.2 million
Free Cash Flow $854.1 million $767.0 million $787.2 million
Total Debt $3,603.9 million $3,239.1 million N/A
Long-Term Debt $3,509.3 million $3,137.5 million N/A
Cash & Equivalents $167.9 million $172.7 million $206.6 million

Material Changes vs. Prior Period

  • Revenue Growth: Worldwide net sales increased 2.5% to $9.29 billion, driven by 4.5% volume growth. Excluding foreign currency translation, sales would have grown 5.0%.
  • Profitability: Operating profit rose 10% to $2.01 billion, and Net Income increased 12% to $1.29 billion. Gross margin improved to 54.6% due to supply chain efficiencies and a focus on higher-margin products.
  • Accounting Changes: The Company adopted SFAS No. 142 (Goodwill and Other Intangible Assets) on Jan 1, 2002, eliminating goodwill amortization. This contributed to a decrease in "Other expense, net" from $94.5 million in 2001 to $23.0 million in 2002.
  • Segment Performance:
    • North America: Sales up 3.0%; Operating profit up 12%.
    • Europe: Sales up 8.0% (aided by a stronger Euro); Operating profit up 19%.
    • Latin America: Sales declined 5.5% due to foreign currency impacts (Venezuela, Argentina, Brazil), though volume grew 2.5%.
    • Pet Nutrition: Sales up 7.0%; Operating profit up 13%.
  • Capital Allocation: The Company repurchased 20.0 million shares for $1.08 billion and increased the common stock dividend to $0.72 per share.

Guidance, Outlook, and Risks

Outlook: Management expects positive momentum to continue in 2003, driven by the success of Colgate toothpaste and new product introductions. Capital expenditures are expected to remain at approximately 4% of net sales.

Key Risks and Contingencies:

  • Brazilian Legal Proceedings: Significant ongoing disputes regarding the 1995 Kolynos acquisition.
    • Central Bank Fine: A fine of approximately $75 million is suspended pending appeal. Management believes it will prevail.
    • Tax Assessment: A tax assessment of approximately $30 million regarding disallowed interest deductions is under appeal.
    • Civil Action: A civil action seeks to make the Company jointly liable for taxes due from the seller's subsidiary.
  • Foreign Currency: Operations in over 200 countries expose the Company to currency fluctuations, particularly in Latin America and Europe.
  • Competition: Intense global competition from multinational companies and private label brands.
  • Raw Materials: Price volatility in commodities like tallow and essential oils.

Investor Verification Checklist

  • Accounting Adjustments: Verify the impact of SFAS 142 on goodwill amortization when comparing 2002 results to prior years (prior years were not restated).
  • Brazilian Contingencies: Monitor the status of the $75 million Central Bank fine and the $30 million tax assessment, as adverse outcomes could impact cash flows.
  • Foreign Exchange Impact: Assess the sensitivity of earnings to currency fluctuations, particularly the Brazilian Real and Argentine Peso, which caused significant translation adjustments.
  • Share Repurchases: Confirm the remaining authorization and execution of the share repurchase program, which significantly reduced shareholders' equity.
  • Pension Assumptions: Review the discount rate (6.75%) and expected return on assets (8.0%) assumptions for pension plans, as changes here materially affect net income.